FDA Inspection 709300 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1937079

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on February 11, 2011 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Louis, MO (United States)